TYMLEZ Stock Plunged On ASX Announcement Of A Partnership With EPI-USE Lab

TYMLEZ Stock Plunged On ASX Announcement Of A Partnership with EPI-USE Lab

As per ASX announcement on 19th December 2018, Tymlez Group Limited (ASX: TYM) and EPI-USE Labs have signed a strategic partnership to provide enterprise blockchain solutions to its clients.

 The partnership of EPI-USE Labs and TYMLEZ will enable an enterprise blockchain solution platform. The platform can be created using the secure cloud infrastructure and services team. This will be implemented across all 47 corporate offices.  EPI-USE operates globally, in Europe, the Americas, UK, Australia, South Africa, the Middle East, and Turkey. It has more than 850 enterprise clients including Kelloggs, Siemens, and Rabobank. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Key highlights

  • TYMLEZ enterprise blockchain solution platform will be benefitted from the partnership by way of securing cloud infrastructure and services team across all global offices.
  • EPI-USE Labs is a global company with over 850 enterprise clients, across 47 countries around the world.
  • Targeting wide enterprise range from start-up to large corporations
  • BaaS subscription fees per user are set at $1,018 per month
  • The Rollout is expected by 1 January 2019

EPI-USE Labs will be offering Blockchain-as-a-Service (BaaS) platform to Tymlez so that it can provide businesses with a ready-to-use, low-cost blockchain subscription services. A spectrum of companies, from start-ups to large corporate organizations, will be able to benefit by using these services. BaaS subscription fees for each user will be $AUD 1,018 per month.

The Tymlez creates ready-made designs, with visual modelling, smart contract and integration capabilities for usage. These have been designed to increase the development of blockchain solutions. Various developers and start-up companies can use the blockchain platform to create enterprise-level blockchain applications.

Michael Reh, the CEO of TYMLEZ said that the company is delighted to make a partnership with EPI-USE. Reh insisted that the network of this partnership significantly increases the selling and implementation capacity and shows strong marketing of the company’s products from the experienced channel partners. The partnership will help to understand the value of using blockchain technology thereby reducing the overall cost of the business. This allows the company to develop Proof of Concepts (POCs) and small testing projects and is an excellent channel for the TYMLEZ platform to achieve growth.

As per Ludi Nel, the CEO of EPI-LABS the company has selected Tymlez as the preferred Blockchain Platform so that Tymlez can assist in unlocking huge potential in large and smaller scales solutions in the enterprise market. By providing this platform to customers, the company will be able to support to bridge the gap the blockchain trend presents in recent times.

The company’s stock is currently trading at $0.130 (down 3.6% as at December 20, 2018, 1:47 PM AEST). The market capitalization of Tymlez stands at 18.3 million.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report